MKI67 and neoplasm: The artificial intelligence-based predictive model allows for non-invasive preoperative assessment of Ki67 expression in SRM patients, enabling preliminary judgment of the tumor’s proliferative capacity, risk, invasiveness, and malignant potential and prognosis, increasing understanding of its natural course.